Company intelligence / Profile preview

GCP ClinPlus

Ownership: Private
Employees: ~500
Development stage: Other

Overview

GCP ClinPlus is a leading China-based contract research organization providing comprehensive clinical research services for pharmaceuticals, biopharmaceuticals, vaccines, cell/gene therapies, medical devices, and more. The company has supported over 2,200 clinical trials globally and played a role in the market launch of more than 180 innovative drugs. Its expertise spans trial design through regulatory submission and data management

Modalities: Small moleculeBiologicVaccineCell therapyGene therapyMedical deviceTraditional Chinese medicineNatural medicine
Industry: Contract Research Organization

Partnerships

CMIC Group joint venture established October 2011Multiple partnerships with multinational pharmaceutical companies and innovative startups

Beyond the preview

Go deeper on GCP ClinPlus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GCP ClinPlus.

Explore the full profile